Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Author: Dumez Herlinde   Gallardo Enrique   Culine Stephane   Galceran Joan Carles   Schöffski Patrick   Droz Jean P.   Extremera Sonia   Szyldergemajn Sergio   Fléchon Aude  

Publisher: MDPI

E-ISSN: 1660-3397|7|3|451-463

ISSN: 1660-3397

Source: Marine Drugs, Vol.7, Iss.3, 2009-09, pp. : 451-463

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content